![Sandy Mahatme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandy Mahatme
Director of Finance/CFO at
VOR BIOPHARMA INC.
Net worth: 550 307 $ as of 2026-06-29
Profile
Sandesh Mahatme currently works at Epirium Bio, Inc., as Director from 2020, Idorsia Ltd., as Non-Executive Director from 2020, Idorsia Pharmaceuticals Ltd., as Director from 2020, CRISPR Therapeutics AG, as Independent Director from 2024, New York State Bar Association, as Member, and Vor Biopharma, Inc., as Chief Financial & Business Officer from 2025.
Mr. Mahatme also formerly worked at Elcelyx Therapeutics, Inc., as Independent Director, Spyre Therapeutics, Inc., as Independent Director from 2015 to 2022, Flexion Therapeutics, Inc., as Independent Director from 2014 to 2021, Celgene Corp., as Senior VP-Finance & Corporate Development from 2006 to 2012, Sarepta Therapeutics, Inc., as Chief Financial & Business Officer, Executive VP from 2017 to 2020, Celgene Switzerland SARL, as Senior Vice President, and National Resilience, Inc., as President, Chief Financial & Operating Officer from 2020 to 2024.
Mr. Mahatme received his graduate degree from Cornell Law School and graduate degree from New York University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IDORSIA LTD. 0.03% | 2024-12-30 | 64,662 ( 0.03% ) | 550 307 $ | 2026-06-29 |
| 2026-06-04 | 0 ( -.--% ) | - $ | 2026-06-29 |
Sandy Mahatme active positions
| Companies | Position | Start |
|---|---|---|
| IDORSIA LTD | Director/Board Member | 2020-05-12 |
| CRISPR THERAPEUTICS AG | Director/Board Member | 2024-05-29 |
| VOR BIOPHARMA INC. | Director of Finance/CFO | 2025-07-08 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Director/Board Member | 2020-10-12 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Director/Board Member | 2020-05-12 |
Former positions of Sandy Mahatme
| Companies | Position | End |
|---|---|---|
National Resilience, Inc.
 National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | President | 2024-05-31 |
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 2022-07-07 |
| FLEXION THERAPEUTICS, INC. | Director/Board Member | 2021-05-31 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Sandy Mahatme
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
Cornell Law School
 Cornell Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Celgene Switzerland SARL
 Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Operates as a global biopharmaceutical company | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Health Technology |
- Stock Market
- Insiders
- Sandy Mahatme
